The growth track for Surgery Partners Inc (SGRY) has changed recently

With 1.28 million shares changed hands, the volume of the stock remained heavier than its average volume of 0.93 million shares. During the session, the Medical Care Facilities company that operates in wider Healthcare sector, reached to the highest price of $33.15 whereas the lowest price it dropped to was $32.32. The 52-week range on SGRY shows that it touched its highest point at $45.79 and its lowest point at $22.05 during that stretch. It currently has a 1-year price target of $43.50. Beta for the stock currently stands at 2.80.

#1 Small-Cap Uranium Stock for Ultra-Fast Gains in 2024

We've uncovered THE ONE small-cap uranium stock that has unearthed a near-surface, high-grade uranium discovery in the Saudi Arabia of Uranium — Canada's prolific Athabasca Basin. Best of all, this small-cap uranium stock is currently flying just below Wall Street's radar… giving you the early-entry opportunity around US$0.30 per share. But that won't last long. Drills are turning right now with results set to be released to the market very, very soon.

Learn all about it in this brand new FREE online report.
Sponsored

Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of SGRY was up-trending over the past week, with a rise of 1.77%, but this was up by 6.53% over a month. Three-month performance surged to 8.07% while six-month performance fell -20.87%. The stock gained 25.91% in the past year, while it has gained 17.73% so far this year. A look at the trailing 12-month EPS for SGRY yields -0.32 with Next year EPS estimates of 0.97. For the next quarter, that number is 0.38. This implies an EPS growth rate of 479.51% for this year and 4.34% for next year. EPS is expected to grow by 75.00% annually over the next five years; however, over the past five years, the company experienced an annual growth rate of 18.22%.


Float and Shares Shorts:

At present, 125.96 million SGRY shares are outstanding with a float of 65.21 million shares on hand for trading. On Nov 29, 2023, short shares totaled 6.44 million, which was 5.09% higher than short shares on Oct 30, 2023. In addition to Mr. Wayne Scott DeVeydt as the firm’s Executive Chairman, Mr. J. Eric Evans serves as its CEO & Director.

Institutional Ownership:

Through their ownership of 107.32% of SGRY’s outstanding shares, institutional investors have majority control over the company. Other institutions hold 84.91% of SGRY, in contrast to 41.66% held by mutual funds. Shares owned by individuals account for 17.94%. As the largest shareholder in SGRY with 13.38% of the stake, Fidelity Management & Research Co holds 16,929,454 shares worth 16,929,454. A second-largest stockholder of SGRY, Wellington Management Co. LLP, holds 8,022,700 shares, controlling over 6.34% of the firm’s shares. The Vanguard Group, Inc. is the third largest shareholder in SGRY, holding 6,528,051 shares or 5.16% stake. With a 3.08% stake in SGRY, the Fidelity Select Port. – Health Ca is the largest stakeholder. A total of 3,900,000 shares are owned by the mutual fund manager. The Fidelity Balanced Fund, which owns about 2.28% of SGRY stock, is the second-largest Mutual Fund holder. It holds 2,880,648 shares valued at 94.34 million. ClearBridge Small Cap Growth Fund holds 2.18% of the stake in SGRY, owning 2,762,807 shares worth 90.48 million.


Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for SGRY since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With SGRY analysts setting a high price target of $50.00 and a low target of $35.00, the average target price over the next 12 months is $43.50. Based on these targets, SGRY could surge 52.44% to reach the target high and rise by 6.71% to reach the target low. Reaching the average price target will result in a growth of 32.62% from current levels.

Summary of Insider Activity:

Insiders traded SGRY stock several times over the past three months with 0 Buys and 0 Sells. In these transactions, 0 shares were bought while 0 shares were sold. The number of buy transactions has increased to 15 while that of sell transactions has risen to 40 over the past year. The total number of shares bought during that period was 277,401 while 159,212 shares were sold.